SANOPHAR
ActiveSummary
SANOPHAR has been active since 2000 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €477,087 and a net result of €98,632. Equity is growing by about 8.6% per year across the filed financial years. Its solvency ranks better than 56% of 5,034 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Group and network
Connections & network
2 connected companiesThe connected companies are in the list below.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Linked via shared directors
APOTHEEK MAERTENS
Shared corporate director
→
Farmave
Shared corporate director
→